ArticleEye (London, England)2026
Endogenous endophthalmitis: a nine-year retrospective study of 33 patients.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEpidemiological and microbiological characteristics of endogenous endophthalmitis (EE) can vary by population and geographical area, with different risk factors. This study from a tertiary care centre aimed to provide additional data from one European country in the field of EE.
methodsThis retrospective study was conducted on patients diagnosed with EE at the University Hospital of Grenoble-Alpes, France, between 2014 and 2023. General and ocular clinical data, along with microbiological findings, were collected at baseline and on follow-up.
resultsThirty-three patients were diagnosed with EE in this study with a mean age of 70 ± 17.7 years, and 51.5% were male. Most cases were unilateral. Common health conditions included cancer, and diabetes mellitus, with endocarditis being the leading source of infection. Baseline visual acuity ranged from 20/20 to no light perception. Blood cultures were positive in 87.8% of the cases. Gram-positive bacteria, especially Staphylococcus aureus, were the most common pathogens, followed by Candida albicans. Pars plana vitrectomy was performed in 33% of the patients. At the end of the follow-up, four patients had lost vision, two developed phthisis, and mortality was reported in 24% of the patients.
conclusionThis study on endogenous endophthalmitis highlights that, in Europe, the primary risk factors are cancer and diabetes, with endocarditis being the most common source of infection. According to our findings, Gram-positive bacteria, particularly Streptococcus species and Staphylococcus aureus, are the most frequently identified pathogens in Europe. These findings differ significantly from reports originating from the USA and Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.